Senti Biosciences is trading 5.51% lower at $0.18 now; no fresh company-specific announcement explaining the October 23 decline surfaced in the search.
- The latest disclosures located concern earlier shareholder approval of the merger and potential reverse split, not a new event today.
- The supplied market context shows the S&P 500 down 0.59% and the Dow down 1.00%.
- Higher oil prices and geopolitical concerns pressured equities, but sources did not establish a direct cause for the stock’s move.